Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(18%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
9%
Ph phase_4
4
36%
Ph not_applicable
4
36%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (11.1%)
Phase 44 (44.4%)
N/A4 (44.4%)

Trials by Status

enrolling_by_invitation19%
completed655%
unknown218%
recruiting218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11